Prokidney Corp.
PROKNasdaqCIK 1850270HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2917:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-438071 |
| 2026-08-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342397 |
| 2026-08-1016:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342373 |
| 2026-05-2916:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-248210 |
| 2026-05-1511:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-225848 |
| 2026-05-1511:47 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-225841 |
| 2026-04-3016:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-018258 |
| 2026-04-1716:05 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001140361-26-015362 |
| 2026-03-1816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-113893 |
| 2026-03-1816:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-113881 |
| 2026-02-0216:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-033594 |
| 2026-01-1207:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009807 |
| 2025-11-1016:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274314 |
| 2025-11-1016:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274303 |
| 2025-10-1716:32 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-242565 |
| 2025-08-1216:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107357 |
| 2025-08-1216:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107352 |
| 2025-07-1507:43 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159041 |
| 2025-07-1417:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158806 |
| 2025-07-0807:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-094445 |
| 2025-07-0113:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-024348 |
| 2025-06-0516:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001315863-25-000444 |
| 2025-05-3016:02 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0000950170-25-079685 |
| 2025-05-1216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069254 |
| 2025-05-1216:17 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069251 |
| 2025-03-1717:22 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040483 |
| 2025-03-1716:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040417 |
| 2025-02-0616:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000080 |
| 2025-01-2116:05 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-25-007217 |
| 2024-11-2216:09 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-24-130207 |
| 2024-11-1216:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125312 |
| 2024-11-1207:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124585 |
| 2024-09-0307:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-102554 |
| 2024-08-0916:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094732 |
| 2024-08-0907:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094341 |
| 2024-06-2516:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-031299 |
| 2024-06-1416:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001315863-24-000510 |
| 2024-06-1309:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-160339 |
| 2024-06-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-157913 |
| 2024-05-3116:19 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-067341 |
| 2024-05-2907:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-027808 |
| 2024-05-1016:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057785 |
| 2024-05-1007:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-057443 |
| 2024-04-2616:28 ET | DEF 14A | Proxy statementPeriod 2024-05-30 | 0001140361-24-022484 |
| 2024-03-2516:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-035914 |
| 2024-03-2220:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034961 |
| 2024-03-2219:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034946 |
| 2024-03-1816:09 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-032827 |
| 2024-03-1816:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-032821 |
| 2024-02-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-013823 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.